Biotechnology
I-Mab Added to FTSE Russell Global Equity Index Series
SHANGHAI and GAITHERSBURG, Md., Sept. 2, 2021 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced that I-Mab will be added to the following FTSE Global Eq...
2021-09-02 20:00
6619
CStone announces China's NMPA has accepted its new drug application for sugemalimab in the treatment of stage III NSCLC
* Sugemalimab becomes the world's first anti-PD-1/PD-L1 monoclonal antibody to significantly improve progression-free survival (PFS) in patients with stage III non-small cell lung cancer (NSCLC) without disease progression after concurrent or sequential chemoradiotherapy * The new drug applic...
2021-09-02 08:05
4593
Innovent and GenFleet Announce Exclusive Global License Agreement for GFH925 (KRAS G12C Inhibitor)
SAN FRANCISCO and SUZHOU, China, Sept. 2, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major dise...
2021-09-02 08:00
6231
Insilico Medicine Collaborates with Gray Matter to Fight Age-related Cognitive Decline
HONG KONG, Sept. 1, 2021 /PRNewswire/ -- Insilico Medicine is pleased to announce an R&D collaboration with Gray Matter, a longevity biotechnology company focused on peptide-based interventions against cognitive decline, age-related CNS diseases, and aging. This strategic partnership is intended ...
2021-09-01 22:08
3868
Hummingbird Bioscience Strengthens Leadership Team with Appointment of Josh House as Chief Financial Officer
HOUSTON and SINGAPORE, Sept. 1, 2021 /PRNewswire/ -- Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets, today announced the appointment of Josh House as Chief Financial Officer, effective immediately. Dr....
2021-09-01 17:00
1744
WuXi Biologics Received First Manufacturing License from Japan and Completed 12 Global Regulatory Inspections in 2021 Year to Date
* Successfully completed 12 regulatory inspections so far this year WUXI, China, Sept. 1, 2021 /PRNewswire/ -- WuXi Biologics (WuXi Bio) (2269.HK), a global company with leading open-access biologics technology platforms, today announced that it has received the Manufacturing License fromJapan'...
2021-09-01 14:12
3946
ETERN Therapeutics Announces Completion of Series B Financing to Advance the Protein Liquid-Liquid Phase Separation Technology Platform and Accelerate the Development of Novel Drugs to Target "Undruggable" Proteins
SHANGHAI, Aug. 31, 2021 /PRNewswire/ -- ETERN Therapeutics, a clinical-stage biotech company focusing on developing novel technologies to target "undruggable" proteins, today announced the completion of a Series B financing round. The financing was co-led by GL Ventures and AstraZeneca-CICC Healt...
2021-09-01 10:00
2059
SynForU(TM)-HerCare probiotics shows benefits to reduce vaginal yeast infection in pregnant women
KAOHSIUNG, Taiwan, Sept. 1, 2021 /PRNewswire/ -- The first clinical study which
has been published in the Journal of Applied Microbiology documents that
SynForU™-HerCare is effective in reducing vulvovaginal symptoms and recurrences
of vaginal candidiasis (VC) in pregnant women.
2021-09-01 09:00
5207
Deebio's Global Bio-enzyme Journey: 27 Years, 30 Countries and Regions
DEYANG, China, Aug. 31, 2021 /PRNewswire/ -- Sichuan Deebiotech Co., Ltd. (hereinafter referred to as Deebio) recently celebrated its 20th anniversary of continuous exports to the EU during the 86th API China. The company's European partners sent congratulatory video, while domestic partners atte...
2021-08-31 19:46
1314
Senhwa's Silmitasertib, COVID-19 Drug Candidate, Receives Positive Interim Review from Data Monitoring Committee to Proceed
TAIPEI and SAN DIEGO, Aug. 31, 2021 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a drug development company focused on first-in-class therapeutics for oncology, rare diseases, and novel coronaviruses, today announced that its oral new drug, Silmitasertib, had received a positive feedbac...
2021-08-31 19:00
2110
Alithea Genomics Launches BRB-Seq Kits for High-Throughput RNA-Seq of Tissue, Cells and Blood Samples
LAUSANNE, Switzerland, Aug. 31, 2021 /PRNewswire/ -- Alithea Genomics, a rapidly growing player in the transcriptomics field, has announced today the launch of its first MERCURIUS BRB-seq kits, which enable high-throughput and cost-efficient RNA-seq library preparation from a wide range of RNA sa...
2021-08-31 19:00
3227
I-Mab Provides Business and Corporate Updates and Reports Financial Results for the Six Months Ended June 30, 2021
* 13 significant clinical milestones achieved year-to-date, including critical positive data readout events for felzartamab (TJ202/MOR202), lemzoparlimab (TJC4), uliledlimab (TJD5), and plonmarlimab (TJM2) and more milestone achievements are expected before the year-end 2021 * Felzartamab (TJ...
2021-08-31 18:00
3924
Harbour BioMed Reports 2021 Interim Results
CAMBRIDGE, Mass.and SUZHOU, China and ROTTERDAM, Netherlands, Aug. 31, 2021 /PRNewswire/ -- Harbour BioMed ("HBM", or the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery, development, and commercialization of novel antibody therapeutics, reported its interim...
2021-08-31 13:47
4249
FamiCord Group investing in stem cell bank owned by Smart Cells Holdings Limited, UK
WARSAW, Poland, Aug. 31, 2021 /PRNewswire/ -- Polski Bank Komórek Macierzystych S.A. (PBKM), which leads the international FamiCord Group,Europe's largest stem cell bank, signed a transaction agreement with shareholders of Smart Cells Holdings Limited, based inLondon UK, to acquire a majority sta...
2021-08-31 09:00
2062
Global Cord Blood Corporation Reports Financial Results for the First Quarter of Fiscal 2022
1Q22 Added 19,673 New Subscribers Revenues Up 12.2% YoY to RMB315.2 Million ($48.8 Million) Gross Profit Up 12.6% YoY to RMB267.3 Million ($41.4 Million) Operating Income Up 17.3% YoY to RMB156.6 Million ($24.2 Million) Non-GAAP Operating Income Up 15.5% YoY to RMB168.5 Million ($26.1 Million) Confe...
2021-08-31 04:16
5133
Viva Biotech Announced 2021 Interim Results
Revenue Increased by 419.5% YoY, CRO Business Income Increased by 62.5% YoY, O rderBacklog Recorded a Significant Increase of 72% Financial Highlights for the 6 months ended June 30, 2021: * Revenue amounted to RMB1,026.5 million, representing a year-on-year (YoY) increase of approximately 419...
2021-08-31 01:32
5749
Through CEO of Hanmi Science, CancerRop Issues KRW 20 Billion New Shares for Cooperation with Oxford Vacmedix
SEOUL, South Korea, Aug. 30, 2021 /PRNewswire/ -- CancerRop (180400), a company specializing in precision medicine and molecular diagnostics, announced a jump start in the global vaccine hub for COVID-19 mRNA (messenger ribonucleic acid) with Hanmi Science through20 billion won worth of investmen...
2021-08-30 23:00
3831
Deebio's Global Bio-enzyme Journey: 27 Years, 30 Countries and Regions
DEYANG, China, Aug. 30, 2021 /PRNewswire/ -- Sichuan Deebiotech Co., Ltd. (hereinafter referred to as Deebio) recently celebrated its 20th anniversary of uninterrupted exports of their products to the EU during the 86th API China. The company's European partners sent congratulatoryvideo, while ...
2021-08-30 21:00
1593
NeuExcell Therapeutics Raises $10+ Million Series Pre-A Round To Continue Its Company Growth
STATE COLLEGE, Pa., Aug. 30, 2021 /PRNewswire/ -- NeuExcell Therapeutics ( www.neuexcell.com), a gene therapy company focusing on neurodegenerative diseases, has announced a $10+ million Series Pre-A financing round. The round was led by Co-Win Ventures, joined by other institutional investors Yua...
2021-08-30 13:00
2340
Miss HK Lisa-Marie Tse Vetted Hong Kong Food Tech Startup Allklear Wraps HK$10M Series Pre-A Funding, Now Valued at almost $100M, Leading New Trends of Healthy Living
HONG KONG, Aug. 30, 2021 /PRNewswire/ -- A Hong Kong food tech startup combining nature and technology, Allklear, has completed Series Pre-A funding, raisingHK$10M from lead investor Gobi Partners, private investor Miss Hong Kong 2020 Lisa-Marie Tse, and co-investors—Chartwell Ventures Limited, V...
2021-08-30 11:53
8984
Week's Top Stories
Most Reposted
Visa and Trip.com Group Ink Strategic Collaboration, Enabling Consumers to Chase Their Passions Through Travel
[Picked up by 309 media titles]
2026-05-19 18:10
Two-day Global Prosperity Summit 2026 officially opens
[Picked up by 308 media titles]
2026-05-19 23:59
Two‑day Global Prosperity Summit 2026 concludes successfully
[Picked up by 303 media titles]
2026-05-21 22:13
Autonomous AI marketing platform Protaigé launches with Maia, the world's first AI Account Director that operates within the flow of work
[Picked up by 281 media titles]
2026-05-20 09:15AIMX Singapore 2026 Anchors Strategic Relationship with TechInnovation and AI Gravity
[Picked up by 279 media titles]
2026-05-19 14:00
Most Read
NYSE Content Update: Lincoln International Pops by 13% in First Day of Trade
2026-05-21 21:04
7344
Scienjoy Holding Corporation Reports Unaudited First Quarter 2026 Financial Results
2026-05-21 20:30
7249
/C O R R E C T I O N -- The American Chamber of Commerce in Singapore (AmChamSG)/
2026-05-21 12:14
6490
NYSE Content Update: Armada Raises $230 Million, Boosts Valuation to $2 Billion
2026-05-19 21:02
6398
